In defiance of global trends, OurCrowd is intensifying its incubator and early-stage investment activity to help grow young technology companies.
Read more here.
In defiance of global trends, OurCrowd is intensifying its incubator and early-stage investment activity to help grow young technology companies.
Read more here.
![[OurCrowd in Jerusalem Post] 86-year-old Copaxone creator has no intention of slowing down](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
